All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 69 points (0.4%) at 16,709 as of Monday, Feb. 29, 2016, 11:55 AM ET. The NYSE advances/declines ratio sits at 2,159 issues advancing vs. 752 declining with 167 unchanged.

The Health Care sector currently sits up 0.1% versus the S&P 500, which is up 0.5%. Top gainers within the sector include

Biomarin Pharmaceutical

(

BMRN

), up 4.4%,

Alibaba Group

(

BABA

), up 3.7%,

Alexion Pharmaceuticals

(

ALXN

), up 1.0%,

Gilead

(

GILD

), up 0.9% and

Abbott Laboratories

(

ABT

), up 0.8%. On the negative front, top decliners within the sector include

Horizon Pharma

(

HZNP

), down 17.0%,

Valeant Pharmaceuticals International

(

VRX

), down 8.6%,

Mylan

(

MYL

), down 2.2%,

Teva Pharmaceutical Industries

(

TEVA

), down 1.5% and

Fresenius Medical Care AG & Co. KGaA

(

FMS

), down 1.4%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3.

Baxter International

(

BAX

) is one of the companies pushing the Health Care sector higher today. As of noon trading, Baxter International is up $0.60 (1.5%) to $40.03 on light volume. Thus far, 1.5 million shares of Baxter International exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $39.38-$40.04 after having opened the day at $39.48 as compared to the previous trading day's close of $39.43.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Baxter International Inc., develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $21.8 billion and is part of the health services industry. Shares are up 3.4% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates

Baxter International

as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Baxter International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Medtronic

(

MDT

) is up $0.77 (1.0%) to $78.06 on light volume. Thus far, 2.0 million shares of Medtronic exchanged hands as compared to its average daily volume of 6.0 million shares. The stock has ranged in price between $77.31-$78.08 after having opened the day at $77.46 as compared to the previous trading day's close of $77.29.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medtronic plc manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $140.3 billion and is part of the health services industry. Shares are up 0.5% year-to-date as of the close of trading on Friday. Currently there are 12 analysts who rate Medtronic a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates

Medtronic

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Medtronic Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

CVS Health

(

CVS

) is up $0.50 (0.5%) to $98.16 on light volume. Thus far, 1.5 million shares of CVS Health exchanged hands as compared to its average daily volume of 5.6 million shares. The stock has ranged in price between $97.20-$98.21 after having opened the day at $97.33 as compared to the previous trading day's close of $97.66.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. It operates through Pharmacy Services and Retail/LTC segments. CVS Health has a market cap of $108.1 billion and is part of the health services industry. Shares are down 0.1% year-to-date as of the close of trading on Friday. Currently there are 17 analysts who rate CVS Health a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates

CVS Health

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

CVS Health Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).